Rare inflammatory disease responds best to the one-two punch of JAK inhibition
St. Jude Children’s Research Hospital scientists showed inhibiting both JAK1 and JAK2 proteins improved hemophagocytic lymphohistiocytosis in models of the inflammatory syndrome.
7-Mar-2024 12:05 PM EST
Add to Favorites